TrialBritish journal of cancer2022

Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial.

Elena Élez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.